|
Information For:
|
Revision BulletinMercaptopurine Tablets
In accordance with the Rules and Procedures of the 2005-2010 Council of Experts, the Biopharmaceutics Expert Committee has revised the Mercaptopurine Tablets monograph by revising the tolerances in Dissolution Test 2 to be in accordance with the U.S. Food and Drug Administration. The Mercaptopurine Tablets Revision Bulletin supersedes the monograph in USP 32-NF 27 until it is printed in the USP 33–NF 28 First Supplement which will be released 1 February 2010 and becomes official 1 August 2010. Should you have any questions, please contact Margareth Marques, Ph.D., (301–816–8106 or . Download the Mercaptopurine Tablets Revision Bulletin What's NewChanges to the Dissolution Performance Verification Test (11/20/09) PF 35(6) Errata (10/30/09) New official Text for October: 15 Revisions Bulletins (10/30/09) Pending Standards for the month of October (10/30/09) PF 35(6), November-December 2009: Highlights and Stimuli Articles (10/23/09) Admission Criteria and Safety Classification for Dietary Supplements Guideline (10/22/09) Elemental Impurities Hot Topics information updated (10/13/09) General Chapter <1151> Pharmaceutical Dosage Forms (10/06/09) Heparin Hot Topics information updated (10/02/09)
Related Resources |
||||||||||||||||||||||||||||
Copyright © 2009 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||